The relevance of estrogen and progestogen choice for breast safety during MHT (EN)

Discover the critical relevance of estrogen and progestogen choice for breast safety during Menopausal Hormone Therapy (MHT) with this on-demand webinar. Don’t miss this illuminating session presented by experts Premitha Damodaran and Tsai Yung-Chieh. Chaired by Dimitrios Goulis, this dynamic discussion explores the intricate relationship between hormone selection and breast health in MHT.

Delve into evidence-based considerations for optimizing breast safety while effectively managing menopausal symptoms. Gain valuable insights into the latest research on estrogen and progestogen choices, addressing breast safety concerns during MHT.

Available in multiple languages, including English, Russian, Spanish, Portuguese, and Mandarin, this webinar offers essential knowledge for healthcare professionals seeking to make informed decisions in MHT.

Don’t miss this opportunity to stay at the forefront of evidence-based practices in menopause care. Watch now and enhance your clinical expertise to provide the best possible care for your patients’ well-being.